Also trades as: MGRO.V (TSXV) · $vol 0M
MGROF OTC
MustGrow Biologics Corp.
1W: +6.1%
1M: +7.6%
3M: +5.7%
YTD: -31.9%
1Y: -34.8%
3Y: -78.3%
5Y: -77.4%
$0.31
+0.01 (+3.33%)
Weekly Expected Move ±8.2%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$4M
-1114.0% ▼
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$4M
-1114.0% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$4M
-1819.3% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$3M | -$3M | -$6M | -$677K | -$5M |
| Depreciation & Amort. | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $777K | $271K | $2M | $1M | $1M |
| Change in Working Capital | $14K | $329K | $604K | -$544K | $109K |
| Other Non-Cash Items | -$59K | $53K | $10K | -$444K | -$272K |
| Operating Cash Flow | -$3M | -$2M | -$3M | -$295K | -$4M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | -$241K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $2M | $2M | $654K | $96K | $0 |
| Financing Cash Flow | $2M | $9M | $654K | $96K | -$241K |
| Net Change in Cash | -$716K | $6M | -$3M | -$199K | -$4M |
| Cash End of Period | $3M | $10M | $7M | $7M | $3M |
| Free Cash Flow | -$3M | -$2M | -$3M | -$295K | -$4M |